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Abstract
A plethora of neurological disorders are associated with alterations in the expression and localization of
potassium-chloride cotransporter type 2 (KCC2), making KCC2 a critical player in neuronal function and an
attractive target for therapeutic treatment. The activity of KCC2 is determined primarily by the rates of its surface
insertion and internalization. Currently the domains of KCC2 dictating its trafficking and endocytosis are unknown.
Here, using live-cell immunolabeling and biotinylation of KCC2 proteins expressed in murine neuroblastoma N2a
cells, human embryonic kidney 293 cells, or primary cultures of rat hippocampal neurons, we identified a novel
role for the intracellular N and C termini in differentially regulating KCC2 surface expression. We report that the
N terminus is required for KCC2 insertion into the plasma membrane, whereas the C terminus is critical for the
membrane stability of KCC2. Our results provide novel insights into the structure–function role of specific KCC2
domains and open perspectives in exploring structural organization of this protein.
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Introduction
A low intracellular chloride concentration ([Cl–]i) is re-
quired for inhibitory synaptic transmission in mature neu-
rons and is maintained by neuron-specific potassium-
chloride cotransporter type 2 (KCC2) which facilitates the
export of chloride ions (Rivera et al., 1999). Decreased
KCC2 activity is linked to the etiology of several neuro-
logic disorders including epilepsy, acute trauma, isch-
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Significance Statement
The neuronal potassium-chloride cotransporter KCC2 is critically involved in numerous neurologic disor-
ders. However, the structural components that regulate KCC2 activity remain to be elucidated. Here, we
describe novel and differential roles for the intracellular N and C terminal domains of KCC2 that dictate its
plasmalemmal insertion and surface stabilization. Our findings challenge the current view on the structure–
function role of the cytoplasmic regions of KCC2 and propose new targets in the search for therapeutic
treatments.
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emia, postsurgery complications, and neuropathic pain
(Blaesse et al., 2009; Kahle et al., 2013; Medina et al.,
2014). In both physiologic and pathologic conditions, the
major mechanism controlling KCC2 function relies on the
control of its surface expression (Chamma et al., 2012;
Kahle et al., 2013; Medina et al., 2014). Although recent
studies have identified a number of KCC2 amino acid
residues involved in its internalization, the domains of
KCC2 that regulate its insertion into the plasma mem-
brane remain unknown (Lee et al., 2007, 2010; Kahle
et al., 2014; Puskarjov et al., 2014; Weber et al., 2014;
Friedel et al., 2015; Stödberg et al., 2015).
The mammalian KCC2 gene (aka Slc12a5) generates
two major isoforms, KCC2a and KCC2b, that differ in their
N termini (Uvarov et al., 2007) and their developmental
and spatial profile of expression (Markkanen et al., 2014).
Historically, the first KCC2 molecule, discovered by Payne
et al. in 1996, was actually the isoform KCC2b; these
days, it is considered the major and most important iso-
form in the adult brain and spinal cord (Payne et al., 1996;
Rivera et al., 1999; Stein et al., 2004; Markkanen et al.,
2014). Mice with knocked out KCC2b are characterized
by increased epileptiform-like neuronal network activity
and die at juvenile age of 2–3 postnatal weeks (Woo et al.,
2002). The KCC2a isoform is expressed in immature neu-
rons of all brain regions but is absent or expressed at a
low level in mature cortex, hippocampus, thalamus, and
cerebellar cortex (Uvarov et al., 2007; Markkanen et al.,
2014). Mice with knocked out KCC2a appear grossly
normal, although their phenotype has not been charac-
terized in detail (Markkanen et al., 2014). Interestingly, a
recent study reported the identification of 11 additional
alternative transcripts of KCC2 that are potentially asso-
ciated with psychiatric disorders in humans; however,
their expression profile and functional importance have
not been studied yet (Tao et al., 2012). Hydrophobicity
analysis of KCC2b amino acid sequence predicted a 2D
structure composed of 12 transmembrane domains flanked
by intracellular/cytoplasmic N and C termini (Payne et al.,
1996). The putative transmembrane region of KCC2 is
composed of 532 amino acids, and N and C termini count
102 and 482 amino acids, respectively (Payne et al.,
1996).
Here, we identified the region on KCC2b isoform that
contributes to the surface insertion of the molecule. Using
live-cell immunolabeling, we analyzed the surface expres-
sion of KCC2b proteins harboring an extracellular pHluo-
rin tag (KCC2-pHext) and missing either intracellular N or C
terminus. We found that the deletion of the N terminal part
of KCC2-pHext (NTD-KCC2-pHext) altered the delivery of
the transporter into the plasma membrane of cultured
hippocampal neurons, neuron-derived cell line (N2a), and
human embryonic kidney 293 (HEK293) cells. Conversely,
the construct composed of the N terminus portion and 12
transmembrane domains only—i.e., deletion of the entire
intracellular C tail (CTD-KCC2-pHext)—was effectively
inserted into the plasma membrane. The compromised
surface expression of NTD-KCC2-pHext was not an ar-
tifact of the extracellular tag, as biotinylation of N2a cells
overexpressing nontagged constructs confirmed the ef-
fective surface labeling of wild-type KCC2 and CTD-
KCC2, but not NTD-KCC2 mutant. Our results identify
the KCC2 N terminus as a region indispensable for
plasma membrane insertion of the transporter and sug-
gest that the large C terminus tail is not critical for this
process, but rather plays a role in KCC2 stabilization at
the cell surface.
Materials and Methods
All manipulations with animals were performed in
agreement with the guidelines of the Animal Care and Use
Committee of INSERM.
Expression constructs
KCC2-IRES-GFP (Chudotvorova et al., 2005), eGFP-
KCC2 (Pellegrino et al., 2011), and KCC2-pHext (Kahle
et al., 2014) were provided by I. Medina. NTD-KCC2 (Li
et al., 2007) was obtained from C. Rivera. Nontagged
wild-type KCC2 (WT-KCC2) was obtained by removal of
the sequence encoding the eGFP tag from eGFP-KCC2.
NTD-KCC2-pHext mutant (deletion of 1–100 amino ac-
ids) was created using PCR. CTD-KCC2 mutant (dele-
tion of KCC2’s 654–1114 amino acids) was made by
deleting the corresponding piece of KCC2 using BamHI
endonuclease. mCherry construct was created by inser-
tion of an ubiquitin promoter instead of CMV promoter in
pmCherry vector (Clontech). All constructs were verified
by DNA sequencing. More details on vectors and con-
structs are available on request.
Primary cultures and transfection of rat hippocampal
neurons
Hippocampal neurons from 18-d-old Wistar rat embryos
of either sex were dissociated using trypsin and plated onto
polyethyleneimine-coated coverslips at a density of 70,000
cells/cm2 in minimal essential medium (MEM) supplemented
with 10% NU serum (BD Biosciences), 0.45% glucose, 1 mM
sodium pyruvate, 2 mM glutamine, and 10 IU/ml penicillin/
streptomycin. On day 9 of culture incubation, half of the
medium was changed to MEM with 2% B27 supplement
(Invitrogen). Transfection of cultured neurons was per-
formed as described by Buerli et al. (2007) and briefly
summarized below. 300 l Opti-MEM medium was mixed
with 7 l Lipofectamine 2000 (Invitrogen), 1 l Magneto-
fection CombiMag (OZ Biosciences), and 1.5 g pre-
mixed DNAs encoding constructs of interest. The mixture
was incubated for 20 min at room temperature and there-
after distributed dropwise above the neuronal culture.
Culture dishes were placed on a magnetic plate (OZ
Biosciences) and incubated for 40 min at 37°C, 5% CO2.
Transfection was terminated by the substitution of 70% of
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the incubation solution with fresh culture medium. Cells
were used in the experiments 3 d after transfection.
Culture and transfection of N2a and HEK293 cells
Mouse neuroblastoma cells (N2a; ATCC, #CCL-131)
and HEK293 cells (ATCC, #CRL-1573) were cultured in
Dulbecco’s modified Eagle’s medium supplemented with
10% FBS and 10 IU/ml penicillin/streptomycin. The cells
were transfected with appropriate pcDNAs using Lipo-
fectamine 2000 (Invitrogen) according to the manufactur-
er’s protocol and used 48–72 h after transfection.
Antibodies for immunocytochemistry
Primary antibodies used for immunocytochemistry
were rabbit polyclonal anti-GFP (dilution 1:500; Invitro-
gen), mouse monoclonal anti-GFP (dilution 1:600; Novus
Biologicals), and rabbit polyclonal anti-DsRed (dilution
1:500; Takara Bio). Secondary antibodies were Cy3-con-
jugated goat anti-rabbit IgG (dilution 1:500; Jackson Im-
munoResearch Laboratories), Alexa Fluor 488–conjugated
goat anti-mouse IgG (dilution 1:500; FluoProbes), and
Alexa Fluor 647–conjugated goat anti-rabbit IgG (dilution
1:500; EMD Millipore). Cell nuclei were revealed using
5-min staining with Hoechst 33258 (1 g/ml, Sigma-
Aldrich).
Gramicidin perforated patch clamp recording
For estimation of [Cl-]i in N2a cells, the cells were
transfected with a mixture of two mammalian expression
constructs encoding the human 1 subunit of the glycine
receptor (GlyR) and KCC2-pHext, eGFP (mock), or KCC2-
IRES-GFP (KCC2). For [Cl-]i measurements in cultured
neurons, 6 d in vitro (DIV) neurons were transfected with
KCC2-pHext, eGFP (mock), or KCC2-IRES-GFP (KCC2).
Measurements were performed 2 or 3 d after transfection
(corresponding to 8 or 9 DIV neurons). Coverslips with
N2a cells or neurons were placed onto the inverted mi-
croscope and perfused with an external solution (in mM):
140 NaCl, 2.5 KCl, 20 Hepes, 20 D-glucose, 2.0 CaCl2, 2.0
MgCl2, and 0.02 Bumetanide, pH 7.4. For recording from
neurons, external solution contained 0.3 M strychnine
and 1 M tetrodotoxin. The recording micropipettes (5
M) were filled with a solution containing (in mM): 150 KCl,
10 Hepes, and 20 g/ml gramicidin A, pH 7.2. Glycine (50
M, for recordings of N2a cells) or isoguvacine (30 M, a
selective agonist of GABAAR for recordings of neurons)
was dissolved in external solution and focally applied to
recorded cells through a micropipette connected to a
Picospritzer (General Valve Corporation, pressure 5 p.s.i.).
Recordings were done with an Axopatch-200A amplifier
and pCLAMP acquisition software (Molecular Devices) in
voltage-clamp mode. Data were low-pass filtered at 2 kHz
and acquired at 10 kHz.
Surface immunolabeling and analysis
Before labeling, half of culture medium was removed
from dishes containing cultured neurons or cell lines and
transferred to a single centrifuge tube containing poly-
clonal rabbit anti-GFP antibody. The mixture was centri-
fuged for 5 min at 8000 rpm, and the supernatant was
placed into the cell culture incubator for at least 30 min (to
equilibrate with CO2 and temperature) and distributed
afterward to dishes containing neurons. Neurons exposed
to the medium containing primary antibody were kept in
the incubator at 37°C for 2 h. The incubation time was
determined experimentally to obtain approximately equal
amounts of fluorescence intensity emitted by surface lo-
cated and internalized clusters in neurons expressing
WT-KCC2-pHext and revealed as described below. After
labeling, cultures were transferred at room temperature to
Hepes-buffered saline and placed for 10 min into the
thermo-isolated box at 13°C. The cells were then incu-
bated at 13°C for 20 min with anti-rabbit Cy3-conjugated
antibody that revealed the plasma membrane KCC2-pHext
pool (Fm). The temperature, time, antibody concentration,
and secondary antibody [Cy3 AffiniPure Goat Anti-Rabbit
IgG (H  L)] were selected to obtain reproducible staining
of KCC2-pHext located on the cell surface (as shown in
single plane images of Fig. 3B, upper raw). Lowering the
temperature to 10°C or increasing the incubation time
with Cy3-conjugated antibody to 40 min resulted in
damage of the plasma membrane (positive staining of
neurons with eGFP-KCC2). Increasing the antibody con-
centration (dilution 1:200) resulted in an increase of the
background fluorescence on nontransfected neurons
without improving the brightness and number of clusters
on the transfected ones. The staining with other second-
ary antibodies conjugated with Cy5, Alexa Fluor 546, 633,
or 647 fluorophores was less effective. After rinsing in a
Hepes-buffered saline solution for 10 min at 13°C, the
cells were fixed in Antigenfix (Diapath) for 20 min (room
temperature), permeabilized (0.3% Triton X-100), blocked
(5% goat serum) for 30 min, and labeled with a second
secondary antibody (anti-rabbit Alexa Fluor 647) for 1 h.
This staining allowed visualization of labeled internalized
proteins (fluorescence signal located inside of the neuron
at individual confocal z-scans, Fig. 3B). The staining with
Alexa Fluor 647 antibody also revealed labeled WT-
KCC2-pHext clusters located on the cell surface (i.e., Cy3-
positive). This indicated that the epitopes on primary
antibodies were not saturated during live-cell staining with
Cy3-conjugated antibody or were unmasked during the
fixation/permeabilization procedure. Therefore, to dissect
the “pure” internalized pool of labeled molecules, the
single-plane images of Alexa Fluor 647 and Cy3 emitted
fluorescence were treated arithmetically afterward as de-
scribed below. To detect the total level of ectopic KCC2-
related proteins expressed, the cells were finally labeled
with mouse anti-GFP antibody (1 h, room temperature)
and revealed with anti-mouse Alexa 488 antibody (1 h,
room temperature).
To reveal all the clusters labeled on the cell surface
(Fall), we omitted the live-cell staining step with the anti-
rabbit Cy3-conjugated antibody and revealed labeled pro-
teins by applying a single secondary anti-rabbit Alexa
Fluor 647 antibody to fixed and permeabilized cells.
For quantitative analysis, images of labeled cells were
acquired with an Olympus Fluorview-500 confocal micro-
scope using oil-immersion objective 60 (NA 1.4), zoom
3, and 15 pixels/m image resolution. We randomly se-
lected and focused on a transfected cell by visualizing
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only Alexa Fluor 488 fluorescence and then acquired
z-stack images of Alexa Fluor 488, Cy3, and Alexa Fluor
647 fluorochromes emitted fluorescence using, respec-
tively, green (excitation 488 nm, emission 505–525 nm),
red (excitation 543 nm, emission 560–600 nm), and infra-
red (excitation 633, emission 660 nm) channels of the
microscope. Each z-stack included 10 planes of 1-m
optical thickness and 0.7 m distance between planes.
The cluster properties and fluorescence intensities of
each cell were analyzed with MetaMorph software (Mo-
lecular Devices Corp.). First, we made subtraction be-
tween Alexa Fluor 647 and Cy3 images to isolate in each
focal plane the Alexa Fluor 647 signal that was not over-
lapping with Cy3 fluorescence. This gave rise to additional
“internalized pool” images. Second, the arithmetic sum-
mation for each z-stack and channel was performed to
collect the whole fluorescence of the different signals
(Alexa Fluor 488; Cy3; internalized pool; Alexa Fluor 647).
Third, a binary mask was created for each cell from Alexa
Fluor 488 image to isolate the signal coming from the
transfected neuron, and the fluorescence parameters (to-
tal fluorescence, single cluster fluorescence, and density
and brightness of clusters) were analyzed for each chan-
nel (Alexa Fluor 488, Cy3, internalized pool, and Alexa
647) in regions overlapping with the binary mask. The
analysis parameters were the same for each experiment,
and all experiments were done blind.
Quantification of KCC2 mutant expression in
neuronal compartments
13 DIV cultured hippocampal neurons cotransfected
with mCherry and KCC2-pHext, NTD-KCC2-pHext, or
CTD-KCC2-pHext were fixed with Antigenfix 48 h after
transfection, then permeabilized and immunolabeled us-
ing rabbit anti-DsRed polyclonal antibody and mouse
anti-GFP antibody followed by Cy3-conjugated anti-
rabbit and Alexa Fluor 488–conjugated anti-mouse. The
confocal images of neurons were taken as described in
the previous paragraph and analyzed using the following
method. For each channel, z-stacks of 10 planes were
converted into a single image using arithmetic summation
with MetaMorph software, and a binary mask was generated
based on Cy3-emitted signal. Alexa Fluor 488 fluorescence
was measured within the binary mask, normalized to Cy3
intensity, and reported as the total expression of KCC2
protein. Regions of interest (ROIs) were then drawn on the
binary mask to identify proximal (40–60 m from soma) and
distal (150–200 m from soma) dendrites. Alexa Fluor 488
fluorescence was measured in each ROI and normalized to
the reference ROI (ref).
SDS-PAGE and Western blot analysis
N2a cells were plated on 35-mm cell culture dishes 24 h
before transfection to obtain 80% confluence at the day of
transfection. Transfections with 1.5 g per dish of DNA
encoding KCC2, KCC2-pHext, NTD-KCC2, NTD-KCC2-
pHext, CTD-KCC2, CTD-KCC2-pHext, or pcDNA3.1 (mock)
were performed using Lipofectamine 2000 according to
the manufacturer’s protocol. 36 h after transfection, the
cells were gently rinsed with ice-cold PBS complemented
with 10 mM iodoacetamide and complete protease inhib-
itor cocktail (Roche), scraped, and centrifuged for 10 min
at 3000  g (4°C). The pellet was dissolved in ice-cold
RIPA buffer (150 mM NaCl, 1% Triton X-100, 0.5% deoxy-
cholate, 0.1% SDS, 50 mM Tris-HCl, and 10 mM iodoac-
etamide, pH 8.0) complemented with complete protease
inhibitor cocktail (Roche). The addition of iodoacetamide
was critical to reduce the formation of KCC2 containing
high-molecular-weight aggregates. Lysates were incu-
bated for 30 min at 4°C with rotation and centrifuged at
1200  g for 5 min to remove debris. Total protein con-
centrations were determined with the micro BCA protein
assay kit (Pierce) using BSA (Sigma-Aldrich) as standard.
Same-day lysates were dissolved in Laemmli buffer (2%
SDS, 20% glycerol, 5% -mercaptoethanol, and 62.5 mM
Tris HCl,pH 7), preheated to 95˚C, and directly loaded to
a SDS-PAGE gel (Bolt 4–12% Bis-Tris Plus precast gels,
Thermo Fisher Scientific, 20 g protein per lane). After
transferring the proteins onto a nitrocellulose membrane
(Thermo Fisher Scientific), the blots were probed first with
chicken anti-KCC2 antibody (KCC2chk, dilution 1:4000),
recognizing the N terminus of the transporter (Markkanen
et al., 2014), and revealed with anti-chicken horseradish
peroxidase (HRP)-conjugated antibodies (1:3000, Invitro-
gen). Thereafter, the secondary antibody was stripped by
3-min incubation at 22°C with Restore PLUS Western Blot
Stripping Buffer (Thermo Fisher Scientific), and mem-
branes were probed with a mixture of anti-KCC2 antibody
(KCC2rab), recognizing the C terminus of the transporter
(dilution 1:5000; US Biological, Euromedex) and mouse
anti–-tubulin antibody (-tub, 1:3000, Thermo Fisher
Scientific). The secondary antibodies were anti-rabbit
HRP-conjugated (1:3000, Invitrogen) and anti-mouse
Cy3-conjugated immunoglobulins (1:2000; Jackson Im-
munoResearch Laboratories). The chemiluminescent
HRP Substrate (Immobilon, WBKLS0500, EMD Millipore)
was used to reveal HRP. All chemiluminescence and flu-
orescence signals were visualized with G:BOX gel imag-
ing system (Syngene) and Genesys software.
Membrane biotinylation assay
N2a cells were plated on 60-mm cell culture dishes 24
h before transfection to obtain 80% confluence at the day
of transfection. Transfections with 5 g per dish of DNA
encoding KCC2, NTD-KCC2, CTD-KCC2, or pcDNA3.1
(mock) were performed using Lipofectamine 2000 accord-
ing to the manufacturer’s protocol. 36 h after transfection,
the cells were gently rinsed with PBS complemented with
0.1 mM CaCl2 and 1 mM MgCl2 (PBS/Ca/Mg) and incu-
bated at 20°C with 2 mg/ml EZ-Link Sulfo-NHS-SS-Biotin
(21945, Thermo Fisher Scientific) in PBS/Ca/Mg for 30
min. The reaction was quenched using PBS/Ca/Mg plus
100 mM lysine (diluted with water to a final osmolarity of
300 mOsm). The cells were then rinsed three times with
PBS/Ca/Mg and lysed in ice-cold RIPA lysis buffer. Ly-
sates were incubated for 30 min at 4°C with rotation and
centrifuged at 1200  g for 5 min to remove debris. Total
protein concentrations were determined with the micro
BCA protein assay kit (Pierce) using BSA (Sigma-Aldrich)
as standard. 20 g of protein were collected and stored
overnight at 4°C (to maintain the same temperature regi-
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men as the fraction that was used for biotinylation pro-
cess). 100 g protein was incubated with streptavidin-
conjugated agarose (20347, Thermo Fisher Scientific)
overnight at 4°C with rotation. The next day, the agarose
with bound biotinylated membrane proteins was washed
three times with ice-cold RIPA buffer and once with ice-
cold PBS. Biotin-labeled proteins were eluted in 50 l
Laemmli buffer preheated to 95˚C (2% SDS, 20% glyc-
erol, 5% -mercaptoethanol, and 62.5 mM Tris HCl, pH 7),
and the entire volume was directly loaded to a SDS-PAGE
gel. The described protocol includes important details
that were experimentally elaborated to decrease the amount
of biotin leakage from the intracellular environment. They
include gentle rinsing of cells, incubation temperature at
20°C (but not 4°C), and the use of lysine instead of glycine
for biotin quenching.
Analysis of Western blots
In agreement with previous reports (Blaesse et al.,
2006; Medina et al., 2014; Friedel et al., 2015), the SDS-
PAGE and Western blot analysis of KCC2 and its mutants
revealed a multiband pattern of transporter migration. The
bottom band reflected migration of the monomeric form
of the protein, whereas upper bands were agglomerates
presumably containing oligomers and protein complexes
formed by interaction with other proteins. The molecular
weight of KCC2 and its mutants was estimated based on
the migration of the monomeric band, whereas for quan-
titative analysis of the total protein expression, the inten-
sity of the entire signal (monomer  agglomerates) was
taken into account as was previously described (Friedel
et al., 2015). As a negative control, we used lysates of
cells transfected with pcDNA3.1 (mock). Band intensities
were quantified using MetaMorph software.
For the biotinylation experiments, the endogenous
transmembrane -transferrin receptor was used as a
loading control for both total cell lysates and biotinylated
extracts. The amounts of total and biotinylated loaded
fractions were adjusted to obtain approximately similar
intensity of WT-KCC2 bands. The intracellular endoge-
nous -tubulin served as a control of biotin leakiness. The
results were quantified as the ratio of biotinylated/total
protein for each KCC2-related construct, -transferrin re-
ceptor, and -tubulin.
Statistical analysis
Statistical analyses were conducted with OriginPro
9.0.0, which also indicated that assumptions of normality
(Shapiro–Wilk test) and equal variance (Brown–Forsythe
test) were met. p  0.05 was considered significant for
these and all subsequent tests. For data displaying nor-
mal distribution, one-way ANOVA and post hoc Tukey test
were used for multiple comparisons between groups. For
data displaying nonnormal distribution, or experiments
with a low number of independent replicates (n  7),
Mann–Whitney U test was used for comparison between
two independent groups and Wilcoxon matched pairs test
to compare paired data.
Results
Cellular expression of KCC2-pHext–related
constructs
To study the role of KCC2 intracellular domains in cell
surface expression of the transporter, we generated
KCC2 fusion proteins in which a pHluorin tag was inserted
into the second putative extracellular loop of KCC2 pro-
tein (KCC2-pHext), and either the N or C terminus of the
protein was deleted (NTD-KCC2-pHext and CTD-KCC2-
pHext, respectively; Fig. 1A). Tagging a membrane protein
is challenging, and problems can occur such as protein
instability, misfolding, aberrant posttranslational modifi-
cations, and functional changes (Maue, 2007). Thus, we
first verified the protein expression level of the KCC2-
related constructs. Whole-cell extracts from N2a cells,
transiently transfected with KCC2-pHext, NTD-KCC2-
pHext, or CTD-KCC2-pHext, were analyzed by Western
blotting using denaturing conditions (Figs. 1B–D). For
comparison, we used a nontagged wild-type KCC2 and
the respective deleted mutants, NTD-KCC2 and CTD-
KCC2.
The upper panel in Fig. 1B shows a representative
Western blot of NTD-KCC2, NTD-KCC2-pHext, KCC2,
and KCC2-pHext, visualized using a polyclonal antibody
that recognizes an epitope located in the C terminus
region of the transporter (anti-KCC2rab). A multiple band
migration pattern was detected, in which the bottom band
corresponds to the monomeric state of the transporter
(Fig. 1B, 140 kDa, indicated with an arrow), whereas the
upper bands account for oligomers or high-molecular-
weight protein complexes that were resistant to denatur-
ing conditions (280 kDa). This migration pattern was
described previously and is typical for the KCC2 trans-
porter (Blaesse et al., 2006; Medina et al., 2014; Friedel
et al., 2015). The insertion of the pHluorin tag in KCC2
protein (KCC2-pHext) produced an expected 28 kDa in-
crease in the molecular weight of the monomer band and
a similar upward shift of the oligomer/protein complex
migration (Fig. 1B). The pattern of migration, the ratio of
monomer to total protein, and the relative amount of total
protein expression were similar for KCC2-pHext and non-
tagged KCC2 (Fig. 1B–D and Table 1).
The deletion of the N terminus region in nontagged KCC2
protein (NTD-KCC2) resulted in an expected downward
shift of both the monomer band (predicted molecular weight,
128 kDa) and the oligomer/protein complexes bands com-
pared with wild-type KCC2 (Fig. 1B). The insertion of the
pHluorin tag in NTD-KCC2 (NTD-KCC2-pHext) provoked
a positive shift in the molecular weight of the monomer
band (up to 146 kDa; Fig. 1B). Remarkably, we observed
that in all experiments, the monomer band of NTD-KCC2
(with or without tag) was barely detectable, whereas the
majority of NTD-KCC2 proteins were concentrated in
high-molecular-weight complexes. Although the total
amount of NTD-KCC2 and NTD-KCC2-pHext protein
expression did not differ from that of wild-type KCC2, we
quantified a significant decrease in the ratio of monomer
to total compared with wild-type KCC2 (Fig. 1C, D and
Table 1). Therefore, the deletion of the N terminus of
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Figure 1. Biochemical properties and expression profile of KCC2-pHext and its mutants with truncated N and C termini. A, Schematic
drawings of KCC2-pHext, NTD-KCC2-pHext, and CTD-KCC2-pHext. The NTD-KCC2-pHext and CTD-KCC2-pHext mutants were
created by deletion of the first 100 amino acids and the last 470 amino acids from, respectively, the N and C termini of KCC2-pHext.
B, Western blot of extracts from N2a cells overexpressing pcDNA3.1 (mock) and indicated KCC2-derived constructs. Arrows indicate
the location of the monomer band for each respective construct. The blot was first revealed using anti-KCC2chk antibody recognizing
KCC2’s C terminus domain and then using anti-KCC2rab antibody raised against N terminus of KCC2b and anti–-tubulin antibody.
Note the weak intensity of monomer band of NTD-KCC2 and NTD-KCC2-pHext mutants. C, Tukey boxplots of the calculated
monomer/total protein ratio for each construct revealed using anti-KCC2rab (top) and anti-KCC2chk (bottom) antibodies. WT, wild-type
KCC2; pH, KCC2-pHext; N, NTD-KCC2; N-pH, NTD-KCC2-pHext; C, CTD-KCC2; C-pH, CTD-KCC2-pHext; six experi-
ments. , p  0.001; , p  0.05; nonparametric Wilcoxon matched pairs test. D, Tukey boxplots of the total expression of
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continued
KCC2-related constructs normalized to the intensity of endogenous -tubulin. No statistically significant difference was detected
between wild-type KCC2 and each particular mutant. Nonparametric Wilcoxon matched pairs test; six experiments (see Table 1 for
the exact p values). E, Representative images of neurons transfected with mCherry and mentioned mutants of KCC2-pHext. The
mCherry was expressed to visualize the morphology of the neuron and was revealed using rabbit polyclonal anti-DsRed antibody and
Cy3-conjugated secondary antibody. The cellular expression of KCC2-pHext was revealed using mouse anti-GFP antibody and Alexa
Fluor 488–conjugated secondary antibody. The fluorescent images of Alexa Fluor 488 were scaled for each neuron to obtain 90%
of maximal intensity in the brightest region and were false-colored using rainbow lookup table shown on the left. The white rectangles
indicate regions where ROIs were drawn and fluorescence intensities measured for quantification shown in G. The high zoom images
were taken at a distance 150–200 m from soma and illustrate KCC2-pHext mutants’ expression in secondary dendrites. Scale bars
are 20 m (left) and 1 m (right). Note that wild-type KCC2-pHext as well as both mutants were expressed in the soma and dendrites,
including the tiny dendrite extremities, but the level of NTD-KCC2-pHext expression was lower in distal dendrites. F, Quantification
of GFP fluorescence intensity (normalized to mCherry) in neurons expressing KCC2-pHext (pH), NTD-KCC2-pHext (N-pH), or
CTD-KCC2-pHext (C-pH). Pooled data from three experiments, four neurons per experiment and condition. No statistical
differences were observed between conditions, Mann–Whitney U test (see Table 1 for details). G, Quantification of GFP fluorescence
intensity in distal (top, corresponding to region 1 in E) and proximal (bottom, corresponding to region 2 in E) dendrites of transfected
neurons. The data were normalized to the fluorescence of a reference region (ref). Pooled data from three experiments, four neurons
per experiment and condition. , p  0.05; , p  0.001, Mann–Whitney U test (see Table 1 for details). For the boxplots, the box
extends from the first (Q1) to third (Q3) quartiles. The line and solid circle inside the box represent median and mean, respectively.
The whiskers define the outermost data point that falls within upper inner and lower inner fence [Q1-1.5(IQR) and Q3-1.5(IQR),
respectively]. Black dots show values of individual measurements.
Table 1. Statistical differences among the samples illustrated in Figures 1 and 2
Location Data reference Data structure Type of test Power
a Fig. 1C, upper panel Nonnormal distribution Wilcoxon matched pairs test
WT vs. pH z 	 1.68, n 	 6; p 	 0.090
WT vs. N z 	 2.09, n 	 6; p 	 0.031
pH vs. N-pH z 	 2.09, n 	 6; p 	 0.031
N vs. N-pH z 	 –0.84, n 	 6; p 	 0.840
b Fig. 1C, lower panel Nonnormal distribution Wilcoxon matched pairs test
WT vs. pH z 	 0, n 	 6; p 	 1.000
WT vs. C z 	 –1.04, n 	 6; p 	 0.312
pH vs. C-pH z 	 0, n 	 6; p 	 1.000
C vs. C-pH z 	 1.46, n 	 6; p 	 0.160
c Fig. 1D, upper panel Nonnormal distribution Wilcoxon matched pairs test
WT vs. pH z 	 –0.21, n 	 6; p 	 0.840
WT vs. N z 	 0, n 	 6; p 	 1.000
pH vs. N-pH z 	 1.25, n 	 6; p 	 0.109
N vs. N-pH z 	 1.35, n 	 6; p 	 0.093
d Fig. 1D, lower panel Nonnormal distribution Wilcoxon matched pairs test
WT vs. pH z 	 –0.63, n 	 6; p 	 0.563
WT vs. C z 	 –1.26, n 	 6; p 	 0.219
pH vs. C-pH z 	 –1.26, n 	 6; p 	 0.922
C vs. C-pH z 	 –1.05, n 	 6; p 	 0.891
e Fig.1 F Nonnormal distribution Mann-Whitney U-test
WT vs. NTD U 	 68, n 	 12,12; p 	 0.843
WT vs. CTD U 	 93, n 	 12,12; p 	 0.242
f Fig. 1G, upper panel Nonnormal distribution Mann–Whitney U test
WT vs. NTD U 	 12, n 	 12,12; p 	 5.8  10–4
WT vs. CTD U 	 36, n 	 12,12; p 	 0.040
g Fig. 1G, lower panel Nonnormal distribution Mann–Whitney U test
WT vs. NTD U 	 72, n 	 12,12; p 	 0.976
WT vs. CTD U 	 62, n 	 12,12; p 	 0.562
h Fig. 2B Normal distribution One-way ANOVA F(2,28) 	 118.15, p 	 2.24  10–14
Mock vs. WT Post hoc Tukey p 	 1.70  10–13
Mock vs. KCC2-pHext Post hoc Tukey p 	 3.75  10
–13
WT vs. KCC2-pHext Post hoc Tukey p 	 0.89
i Fig. 2C Normal distribution One-way ANOVA F(2,29) 	 12.46, p 	 1.24  10–4
Mock vs. WT Post hoc Tukey p 	 2.36  10–4
Mock vs. KCC2-pHext Post hoc Tukey p 	 8.85  10
–4
WT vs. KCC2-pHext Post hoc Tukey p 	 0.95
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KCC2 does not perturb protein translation but signifi-
cantly enhances the ability of the transporter to form
multimolecular complexes resistant to denaturing condi-
tions.
The lower panel of Fig. 1B illustrates the migration
pattern of KCC2, KCC2-pHext, CTD-KCC2, and CTD-
KCC2-pHext visualized on the same Western blot but
using a polyclonal antibody that recognizes an epitope
localized on the N terminus domain of the transporter
(anti-KCC2chk). The monomer band of CTD-KCC2 mi-
grated close to the predicted position of 71 kDa (Fig. 1B),
and the ratio monomer/total protein did not statistically
differ from those of wild-type KCC2 (Fig. 1B, C and
Table 1). Although the high-molecular-weight complexes
of CTD-KCC2 exhibited smear-like migration patterns
whose aspect varied from one experiment to another
(compare Figs. 1B and 7B ), the total intensity of CTD-
KCC2 protein did not differ from that of wild-type KCC2
(Fig. 1B, D and Table 1). The insertion of a pHluorin tag
into CTD-KCC2 protein produced an upward shift of
both monomer and oligomer/protein complexes (CTD-
KCC2-pHext, Fig. 1B) with a similar smear-like pattern for
the high-molecular-weight complex. The consistency of
molecular weight for CTD-KCC2 monomer bands sug-
gests that the mutant was correctly transcribed and trans-
lated. However, the deletion of the C terminus formed a
smear-like migration pattern for the high-molecular-weight
complexes.
Next, to assess the subcellular distribution of created
mutants, we transfected cultured hippocampal neurons
with a mixture of plasmids encoding KCC2-pHext–derived
constructs and mCherry, to visualize the neuron morphol-
ogy (Fig. 1D). Both NTD-KCC2-pHext and CTD-KCC2-
pHext mutants were expressed in the form of clusters in
the soma, proximal, and distal dendrites. The total inten-
sity of fluorescence emitted by NTD-KCC2-pHext and
CTD-KCC2-pHext neurons and normalized to the fluo-
rescence of mCherry was not statistically different from
that of wild-type KCC2-pHext (Fig. 1E, F and Table 1).
Similarly, there was no statistically significant difference in
the relative level of mutants expression in proximal den-
drites (Fig. 1E, G and Table 1). However, the relative
amount of protein expression in distal dendrites was two-
fold lower for NTD-KCC2-pHext (p 	 5.8  10
–4, Mann–
Whitney U test, Fig. 1E, G and Table 1) and higher for
CTD-KCC2-pHext (p 	 0.04, Mann–Whitney U test, Fig.
1E, G and Table 1) compared to KCC2-pHext.
In overall, the insertion of a pHluorin tag in the extra-
cellular loop of KCC2 mutants did not disturb the bio-
chemical properties of the proteins compared to their
nontagged homologs. Although the deletion of either N or
C terminus of KCC2 did slightly perturb the migration
pattern of the proteins as well as their distal dendrite
localization, the proteins are effectively transcribed, trans-
lated, and expressed in neurons.
Functionality of KCC2-pHext
To examine whether the insertion of the pHluorin tag
may compromise KCC2 function, we coexpressed the
KCC2-pHext with glycine receptor-channels (GlyR) in N2a
cells and recorded the reversal potential of GlyR (EGly),
which is principally determined by [Cl-]i, using gramicidin-
perforated patch-clamp technique. The cells expressing
KCC2-pHext were recognized through the weak fluores-
cence emitted by the pHluorin. For comparison, we used
cells expressing eGFP only (mock) and cells expressing
nontagged KCC2 subcloned in pIRES-GFP vector (Chu-
dotvorova et al., 2005). Figure 2A shows an example of
recording obtained for a KCC2-pHext or mock-transfected
cell. We found that the [Cl-]i calculated from EGly using
the Nernst equation was much lower in KCC2-pHext–
expressing cells than in mock-transfected cells (statisti-
cally significant difference, p	 3.75 10
13; Table 1) and
was similar to the one recorded in cells expressing
nontagged KCC2 (p 	 0.89, Fig. 2B and Table 1). These
data indicated that KCC2-pHext overexpressed in a het-
erologous expression system was functional and did not
differ from nontagged KCC2 in its ability to extrude Cl-.
In its native neuronal environment, KCC2 interacts with
at least eight partners (Medina et al., 2014); some of them
are neuron restricted and control KCC2 activity (e.g.,
Neto2; Ivakine et al., 2013). To assess whether KCC2-
pHext is active when expressed in neurons, we overex-
pressed the construct in cultured immature hippocampal
neurons at developmental stage 8–9 DIV, characterized
by low functional activity of endogenous KCC2 and
relatively high level of [Cl-]i (Chudotvorova et al., 2005;
Pellegrino et al., 2011; Friedel et al., 2015). The measure-
ments of the reversal potential of Cl- permeable GABAA
receptor-channel (GABAAR) responses revealed statisti-
cally significant decrease of [Cl-]i in neurons expressing
KCC2-pHext compared to mock-transfected neurons (Fig.
2C and Table 1). [Cl-]i in neurons expressing KCC2-pHext
was indistinguishable from that measured in neurons
transfected with nontagged KCC2. Thus, KCC2-pHext ef-
fectively reduces [Cl-]i when expressed in either a heter-
ologous expression system or cultured hippocampal
neurons.
Surface labeling of KCC2-pHext mutants with deleted
intracellular regions
Next we assessed the abundance of KCC2-pHext,
NTD-KCC2-pHext, and CTD-KCC2-pHext in different
cell compartments of 13 DIV hippocampal neurons using
the previously described live-cell surface protein immu-
nolabeling protocol (Fig. 3A; Friedel et al., 2015). Namely,
we labeled the extracellular tag of KCC2-pHext using poly-
clonal rabbit anti-GFP antibody during 2 h on living neu-
rons and under normal culturing conditions (37°C, 5%
CO2). Presumably, at the end of this procedure, some of
the labeled molecules remained on the cell surface,
whereas others were internalized. The labeled molecules
that were retained on the cell surface were visualized
using secondary Cy3 conjugated anti-rabbit antibody ap-
plied to the living cells at low temperature (13°C), to
prevent further protein internalization; the resulting fluo-
rescence was identified as membrane fluorescence (Fm).
This live-cell labeling protocol revealed small (0.5 m)
and distinct clusters of different intensity that were re-
stricted to the cell surface, as it is illustrated with images
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taken at different z-planes (Fig. 3A and first raw images in
Fig. 3B). These clusters resembled by their form and size
the live-cell labeled clusters of another KCC2 construct
harboring 3xFlag as an extracellular tag (Chamma et al.,
2013). The second pool of molecules, corresponding to
KCC2-pHext labeled and internalized, was visualized after
post hoc fixation of the same cells and additional labeling
with Alexa Fluor 647–conjugated anti-rabbit antibody.
The Alexa Fluor 647–emitted fluorescence signal ob-
tained was mainly restricted to the intracellular compart-
ments, but also revealed partially the Cy3-positive
clusters retained on the cell surface (Fig. 3A and second
raw images in Fig. 3B). The “pure” internalized pool of
fluorescence (Fi) was then obtained after arithmetic sub-
traction of Alexa Fluor 647 and Cy3 images (Fig. 3A and
fourth raw images in Fig. 3B). To quantify the total amount
of overexpressed KCC2-pHext, neurons were then labeled
with mouse monoclonal anti-GFP antibody and revealed
using Alexa Fluor 488 conjugated antibody (Ft, total fluo-
rescence intensity, third raw images in Fig. 3B). The spec-
ificity of KCC2-pHext–related constructs surface labeling
was verified using eGFP-KCC2 construct that carried a
tag linked to the intracellular N terminus of KCC2. The
surface immunolabeling of neurons expressing eGFP-
KCC2 did not reveal regularly distributed Cy3 or Alexa
Fluor 647–positive clusters. Only rare clusters of signifi-
cantly weaker fluorescence intensity contributed to for-
mation of the background signal (Fig. 4A, second images
raw).
Although the four tested constructs (KCC2-pHext,
NTD-KCC2-pHext, CTD-KCC2-pHext, and eGFP-KCC2)
were well expressed into neurons and showed similar
intensities of Ft, the amount of surface labeled fluorescent
clusters strongly varied depending on the expressed mol-
ecule (Fig. 4A, B and Table 2). Unlike neurons expressing
wild-type KCC2-pHext, the cells with NTD-KCC2-pHext
mutant were not decorated with bright puncta, resulting in
a significantly lower Fm (Fig. 4A, B and Table 2). The
brightness and density of rare fluorescent Fm clusters
detected on NTD-KCC2-pHext neurons were signifi-
cantly less than those of KCC2-pHext and were reminis-
cent of those characterizing the background staining of
control neurons with eGFP-KCC2 (Fig. 4C and Table 2).
As a consequence, the population data describing the
intensity of Fm signal in individual neurons were signifi-
cantly lower in NTD-KCC2-pHext, as compared to KCC2-
pHext, and did not differ from eGFP-KCC2–transfected
cells (Fig. 4B, plot Fm, and Table 2). Unlike NTD-KCC2-
pHext, the neurons expressing CTD-KCC2-pHext con-
struct had clearly detectable clusters located in the
plasma membrane (Fig. 4A, fourth images raw). The den-
sity of these clusters was similar to the one visualized on
neurons with wild-type KCC2-pHext, but their brightness
was statistically significantly weaker (Fig. 4C and Table 2).
The intensity of Fm emitted by CTD-KCC2-pHext neurons
was significantly lower as compared to wild-type KCC2-
pHext, but was significantly higher as compared to NTD-
KCC2-pHext neurons and control eGFP-KCC2-positive
cells (Fig. 4B, plot Fm, and Table 2).
The decreased surface expression of NTD-KCC2-
pHext and CTD-KCC2-pHext mutants could be the result
of reduced surface delivery of the molecules or enhanced
internalization processes. Analysis of the fluorescence
intensity of immunolabeled and internalized clusters re-
vealed no detectable Fi signal in neurons expressing NTD-
KCC2-pHext mutant (Fig. 4A, B), and thus, indicated that
the deletion of N terminus prevented delivery of the KCC2
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Figure 2. Recombinant KCC2-pHext is functional. A, Traces
show representative currents induced by focal applications of
glycine to N2a cells expressing KCC2-pHext or eGFP (mock) at
different voltage steps. In the I-V plot, GlyR-mediated current
amplitudes were plotted against holding membrane potential.
The current intercepts the voltage axis at EGly (–89 and –41 mV
for KCC2-pHext and eGFP, respectively). The numbers above
interception points indicated quantified using the Nernst equa-
tion [Cl–]i values. B, Tukey boxplots of the calculated [Cl
–]i values
measured as shown in A for N2a cells expressing KCC2-pHext,
eGFP (mock), or KCC2-IRES-GFP (KCC2). Pooled data from four
cultures, five to eight cells per culture and condition. , p 
0.001; ns, nonsignificant; one-way ANOVA and post hoc Tukey
test (see Table 1 for details). C, Calculated [Cl–]i from EGABAA
measurements in 8- to 9-DIV neurons expressing KCC2-pHext,
eGFP (mock), or KCC2-IRES-GFP (KCC2). Eight cultures, two to
three neurons per culture and condition. , p  0.01; ns,
nonsignificant; one-way ANOVA.
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Figure 3. Visualization of surface expressed and internalized KCC2-pHext proteins using a live-cell immunolabeling protocol on
cultured hippocampal neurons. A, Scheme of the multistep immunolabeling protocol applied to 13 DIV neurons. First Ab, primary
antibody; second Cy3, Cy3-conjugated secondary antibody; second Alexa 647, Alexa Fluor 647–conjugated secondary antibody;
PFA, paraformaldehyde. The scheme does not include final steps of fixed and permeabilized cells labeled with mouse anti-GFP and
anti-mouse Alexa Fluor 488 antibody [total protein pool (Ft)]. B, Representative images showing fluorescence emitted after staining
with Cy3-conjugated secondary antibody [plasma membrane restricted pool (Fm)]; images were pseudocolored using illustrated
bicolor lookup table, first raw); Alexa Fluor 647–conjugated secondary antibody (internalized surface labeled molecules and portion
of surface retained molecules, second raw); Alexa Fluor 488–conjugated secondary antibody (Ft, third raw); internalized surface
labeled signal obtained by arithmetic subtraction of first and second raw images (Fi, fourth raw). Image columns illustrate fluorescent
signals obtained at different z-planes or after arithmetic summation of nine planes as indicated. The neuronal shape (Alexa Fluor 488
fluorescence) is shown in light green in each image for reference. Insets illustrate indicated portions of images at higher zoom. Scale
bars: 8 m (main image), 1 m (insets).
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into the plasma membrane. In contrast to neurons with
NTD-KCC2-pHext, the cells expressing CTD-KCC2-
pHext construct exhibited 10-fold higher rate of internal-
ization (statistically significant difference, p 	 2.86 
10
6, Fig. 4B, plot Fi, and Table 2).
The decreased surface delivery of NTD-KCC2-pHext
mutant was further confirmed in another set of experi-
ments with modified live staining protocol (see Materials
and methods for details) designed to visualize all mole-
cules labeled on the cell surface during a 2-h period (Fig.
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Figure 4. Surface expression of KCC2-pHext mutants with deleted intracellular N and C termini in cultured hippocampal neurons. A,
Schematic drawings of KCC2-pHext mutants and representative images showing fluorescence emitted after total protein staining (Ft)
by plasma membrane restricted pool (Fm) and internalized pool of labeled molecules (Fi). Images illustrate the fluorescence obtained
after the summation of 10 z-planes acquired for each channel as described in Figure 3B. B–D, Summary data of indicated
morphometric parameters characterizing surface expression of mutants (values were normalized to mean KCC2-pHext in each
experiment). The protocol used to determine the Fall depicted in D is described in Materials and Methods. Pooled data from four
cultures, four to eight neurons per culture and condition. , p  0.001, Mann–Whitney nonparametric test (see Table 2 for more
details). Parameters of boxplots are the same as detailed in Figure 1.
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4D). Any labeled clusters were detected on NTD-KCC2-
pHext–positive neurons; the median value of Fall signal mea-
sured on NTD-KCC2-pHext cells was20-fold lower than
that of wild-type KCC2-pHext neurons (0.04 and 0.92,
respectively, p 	 2.64  10
13; Fig. 4D and Table 2).
Moreover, the distribution of the Fall values in NTD-
KCC2-pHext neurons was similar to that measured in
eGFP-KCC2-positive cells (nonsignificant difference, p 	
0.2; Fig. 4D and Table 2). Unlike NTD-KCC2-pHext, the
Fall signal in CTD-KCC2-pHext–positive neurons was well
detectable and was even significantly stronger than that in
wild-type KCC2-pHext (correspondent medians were 1.45
and 0.92, p 	 9.56  10
4; Fig. 4D and Table 2). We
concluded, therefore, that the deletion of the N terminus
of KCC2-pHext fully abolished plasmalemmal delivery of
the protein, whereas a construct composed only of the N
terminus and transmembrane regions was well delivered
to the cell surface. Once expressed into the plasma mem-
brane, CTD-KCC2-pHext proteins were rapidly internal-
ized, which accounted for the twofold lower amount of Fm
and higher amount of Fi compared with wild-type KCC2-
pHext. Taken together, these data indicated that N termi-
nus is indispensable for surface delivery of KCC2-pHext.
Surface expression of KCC2-pHext mutants in
heterologous cell lines
The neuronal environment is crucial for KCC2 function
and regulation, and Li et al. (2007) found that NTD-KCC2
was expressed in the plasma membrane of HEK293 cells.
Therefore, we asked whether the surface delivery of
NTD-KCC2-pHext mutant is also compromised in cell
lines. We examined the expression of nonmutated KCC2-
pHext, NTD-KCC2-pHext, and CTD-KCC2-pHext mu-
tants in two different cell lines, neuron-derived N2a and
nonneuronal HEK293 cells.
As in neurons, we found that in both cell lines the
deletion of the N terminus of KCC2-pHext fully abolished
the mutant’s surface expression, whereas the CTD-
KCC2-pHext construct composed of N terminus and trans-
membrane regions was well labeled on the cell surface
Table 2. Statistical differences among the samples illustrated in Figure 4
Location Data reference Data structure Type of test Power
a Fig. 4B, plot Ft Nonnormal distribution Mann–Whitney U test
eGFP-KCC2 vs. WT U 	 185, n 	 19,24; p 	 0.30
WT vs. NTD U 	 161, n 	 24,20; p 	 0.06
WT vs. CTD U 	 357, n 	 24,30; p 	 0.97
NTD vs. CTD U 	 274, n 	 20,30; p 	 0.72
b Fig. 4B, plot Fm Nonnormal distribution Mann–Whitney U test
eGFP-KCC2 vs. WT U 	 9, n 	 19,24; p 	 2.42  10–10
WT vs. NTD U 	 476, n 	 24,20; p 	 1.36  10–11
WT vs. CTD U 	 568, n 	 24,30; p 	 1.89  10–4
NTD vs. CTD U 	 26, n 	 20,30; p 	 4.96  10–10
eGFP-KCC2 vs. NTD U 	 220, n 	 19,20; p 	 0.4
eGFP-KCC2 vs. CTD U 	 47, n 	 19,30; p 	 1.09  10–6
c Fig. 4B, plot Fi Nonnormal distribution Mann–Whitney U test
eGFP-KCC2 vs. WT U 	 420, n 	 19,24; p 	 2.28  10–7
WT vs. NTD U 	 476, n 	 24,20; p 	 1.36  10–11
WT vs. CTD U 	 106, n 	 24,30; p 	 2.86  10–6
NTD vs. CTD U 	 8, n 	 20,30; p 	 2.84  10–12
eGFP-KCC2 vs. NTD U 	 230, n 	 19,20; p 	 0.24
eGFP-KCC2 vs. CTD U 	 14, n 	 19,30; p 	 2.58  10–8
d Fig. 4C, single Fm Nonnormal distribution Mann–Whitney U test
eGFP-KCC2 vs. WT U 	 14, n 	 19,24; p 	 1.27  10–9
WT vs. NTD U 	 447, n 	 24,20; p 	 7.95  10–12
WT vs. CTD U 	 647, n 	 24,30; p 	 5.59  10–8
NTD vs. CTD U 	 14, n 	 20,30; p 	 2.16  10–11
eGFP-KCC2 vs. NTD U 	 242, n 	 19,20; p 	 0.15
eGFP-KCC2 vs. CTD U 	 70, n 	 19,30; p 	 1.08  10–5
e Fig. 4C, Fm density Nonnormal distribution Mann–Whitney U test
eGFP-KCC2 vs. WT U 	 16, n 	 19,24; p 	 2.28  10–9
WT vs. NTD U 	 470, n 	 24,20; p 	 1.58  10–10
WT vs. CTD U 	 452, n 	 24,30; p 	 0.11
NTD vs. CTD U 	 33, n 	 20,30; p 	 2.25  10–9
eGFP-KCC2 vs. NTD U 	 206, n 	 19,20; p 	 0.66
eGFP-KCC2 vs. CTD U 	 58, n 	 19,30; p 	 3.36  10–6
f Fig. 4D Nonnormal distribution Mann–Whitney U test
eGFP-KCC2 vs. WT U 	 0, n 	 33,40; p 	 2.64  10–13
WT vs. NTD U 	 1480, n 	 40,37; p 	 4.69  10–14
WT vs. CTD U 	 538, n 	 40,46; p 	 9.56  10–4
NTD vs. CTD U 	 0, n 	 37,46; p 	 6.56  10–15
eGFP-KCC2 vs. NTD U 	 719, n 	 33,37; p 	 0.2
eGFP-KCC2 vs. CTD U 	 0, n 	 33,46; p 	 4.65  10–14
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(Fig. 5A). The relative intensities of Fm and Fi signals in
HEK293 and N2a cell lines expressing CTD-KCC2-pHext
mutant resembled those analyzed in neurons (Fig. 5B and
Table 3). We concluded, therefore, that the N terminus is
essential for the plasmalemmal delivery of KCC2-pHext
regardless of the expression system. Of note, we found
that wild-type KCC2-pHext was labeled on the cell surface
of 98% of studied neurons and 99% of N2a cells but only
62% of HEK293 cells (Fig. 6), indicating a possible differ-
ence in the mechanisms controlling KCC2 surface deliv-
ery in N2a and HEK293 cell lines.
Biotinylation of KCC2 mutants
To exclude a possible contribution of the extracellular
tag to the mutant surface delivery and internalization, we
analyzed the surface expression of nontagged wild-type
KCC2, NTD-KCC2, and CTD-KCC2 proteins using bi-
otinylation assay in N2a cells followed by SDS-PAGE
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separation and Western blotting (Fig. 7). As in the Western
blot analysis depicted in Figure 1, the expression of
NTD-KCC2 mutant was visualized using anti-KCC2rab
antibody recognizing the C terminus of KCC2 (Fig. 7A),
whereas the expression of CTD-KCC2 mutant was de-
tected with anti-KCC2chk antibody recognizing the N ter-
minus of the transporter (Fig. 7B). In the same samples,
we also characterized the cellular expression and surface
biotinylation level of the transmembrane -transferrin re-
ceptor (-tr) and cytoplasmic -tubulin (-tub). -tr label-
ing was used as a positive control for biotinylation efficacy
and loading of total and biotinylated protein fractions.
-tub, an intracellular protein that should not be biotinyl-
ated, was used as a negative control to determine the
level of inevitable leakage of the biotinylation compound
into the intracellular environment. Special attention was
given to the improvement of the experimental protocol,
with the purpose of decreasing biotin leakage (see Mate-
rials and Methods for details). We quantified the intensity
of each band and expressed the results as the ratio of
biotinylated to total protein for -tr, -tub, and KCC2 (Fig.
7C, D). As illustrated in Figure 7A and quantified in Figure
7C, the biotinylated/total protein ratio was significantly
lower in neurons expressing NTD-KCC2 compared with
neurons expressing WT-KCC2. Moreover, consistent with
experiments involving NTD-KCC2-pHext (Fig. 5), the bioti-
nylation level of NTD-KCC2 was indistinguishable from
that of leakage biotinylation revealed using -tub antibody (p
	 0.69; Fig. 7C and Table 4). Unlike the NTD-KCC2 mu-
tant, the level of the surface labeling of CTD-KCC2 mutant
was not statistically different from the labeling of WT-KCC2
(p 	 0.92; Fig. 7B and Table 4) and was significantly higher
than the level of surface unrelated labeling of -tub in the
same cell sample (p 	 0.02; Fig. 7D and Table 4). We
concluded, therefore, that the truncation of the N terminus of
naive KCC2 prevented plasmalemmal expression of the
transporter, whereas the truncation of the C terminus did not
affect this process.
Discussion
In the present work, we demonstrated that KCC2-pHext
is a suitable and useful tool to assess the membrane
expression of exogenous KCC2 proteins in neurons and
heterologous systems. We found that the N terminus is
required for KCC2 insertion into the plasma membrane,
regardless of the expression system, whereas the C ter-
minus is critical for the membrane stability of KCC2. Our
results suggest that cargo proteins responsible for KCC2
trafficking to the plasma membrane are interacting with
regions other than the C terminus and highlight the N
terminus of KCC2 as a critical element for this mechanism
(Fig. 8).
We took advantage of the KCC2-pHext construct to
analyze the role of the intracellular tails in the plasma
membrane expression and internalization of KCC2. Al-
though questions about the role of diverse mutations and
structural elements on KCC2 surface expression are of
primary importance, the relatively low percentage of en-
Table 3. Statistical differences among the samples illustrated in Figure 5
Location Data reference Data structure Type of test Power
a Fig. 5B, Fall HEK Nonnormal distribution Mann–Whitney U test
eGFP-KCC2 vs. WT U 	 995, n 	 70,109; p 	 2.18  10–19
WT vs. NTD U 	 11412, n 	 109,117; p 	 2.48  10–29
WT vs. CTD U 	 4182, n 	 109,106; p 	 4.32  10–4
NTD vs. CTD U 	 1015, n 	 117,106; p 	 2.36  10–33
b Fig. 5B, Fall N2a Nonnormal distribution Mann–Whitney U test
eGFP-KCC2 vs. WT U 	 16, n 	 23,24; p 	 1.13  10–10
WT vs. NTD U 	 552, n 	 24,23; p 	 1.24  10–13
WT vs. CTD U 	 173, n 	 24,27; p 	 0.004
NTD vs. CTD U 	 9, n 	 23,27; p 	 1.80  10–12
c Fig. 5B, Fm HEK Nonnormal distribution Mann–Whitney U test
eGFP-KCC2 vs. WT U 	 1076, n 	 61,109; p 	 8.23  10–15
WT vs. NTD U 	 10352, n 	 109,117; p 	 1.88  10–17
WT vs. CTD U 	 6428, n 	 109,106; p 	 0.15
NTD vs. CTD U 	 2320, n 	 117,106; p 	 2.34  10–17
d Fig. 5B, Fm N2a Nonnormal distribution Mann–Whitney U test
eGFP-KCC2 vs. WT U 	 11, n 	 23,24; p 	 2.42  10–11
WT vs. NTD U 	 546, n 	 24,23; p 	 3.72  10–12
WT vs. CTD U 	 679, n 	 24,38; p 	 0.0010
NTD vs. CTD U 	 33, n 	 23,38; p 	 2.86  10–12
e Fig. 5B, Fi HEK Nonnormal distribution Mann–Whitney U test
eGFP-KCC2 vs. WT U 	 1356, n 	 61,109; p 	 2.40  10–11
WT vs. NTD U 	 10638, n 	 109,117; p 	 3.26  10–14
WT vs. CTD U 	 2362, n 	 109,106; p 	 5.77  10–15
NTD vs. CTD U 	 479, n 	 117,106; p 	 1.19  10–32
f Fig. 5B, Fi N2a Nonnormal distribution Mann–Whitney U test
eGFP-KCC2 vs. WT U 	 41, n 	 23,24; p 	 3.03  10–8
WT vs. NTD U 	 548, n 	 24,23; p 	 1.49  10–12
WT vs. CTD U 	 142, n 	 24,38; p 	 1.62  10–6
NTD vs. CTD U 	 11, n 	 23,38; p 	 1.04  10–14
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dogenous KCC2 expressed at the plasma membrane and
the absence of specific antibody recognizing extracellular
domains of the transporter make these questions chal-
lenging. To circumvent these limitations, a number of
KCC2 chimeras with tags in the extracellular loops were
created and successfully used to characterize the surface
expression of different mutants (Zhao et al., 2008; Acton
et al., 2012; Chamma et al., 2013; Weber et al., 2014).
Along this line, KCC2-pHext, was previously used to char-
acterize the surface expression of KCC2 mutants associ-
ated with human idiopathic generalized epilepsy (Kahle
et al., 2014) and describe the functional significance of
KCC2’s Thr906 and Thr1007 phosphorylation sites (Frie-
del et al., 2015). In the present study, we performed a
detailed analysis of the biochemical and biophysical prop-
erties of KCC2-pHext. We demonstrated that the insertion
of the pHluorin tag does not affect the migration pattern of
KCC2 and preserves its ion transport ability. More impor-
tantly, the pHluorin tag did not modify the migration pat-
tern of mutants with deleted N and C termini and yielded
discoveries about novel roles of intracellular tails in sur-
face expression of KCC2.
Our main discovery is the critical role of the N terminus
for the surface delivery of KCC2. This finding was unex-
pected, as a previous study illustrated the effective bioti-
nylation (e.g., surface expression) of NTD-KCC2 in
HEK293 cells (Li et al., 2007). The cited work was, how-
ever, qualitative and did not provide quantitative analysis
or take into account controls of the biotin leakiness in
cells expressing KCC2 and NTD-KCC2. So far, no other
studies have been performed to address the question of
the role of the N terminus for proper surface delivery of
KCC2. We have found that decreased surface expression
of NTD-KCC2-pHext mutant is the result of perturbed
protein surface delivery, whereas decreased surface ex-
pression of CTD-KCC2-pHext mutant is consequent to
an enhanced protein internalization rate. These results
were further confirmed using a biotinylation approach and
nontagged KCC2 constructs.
What clues explain the default of NTD-KCC2 expres-
sion at the plasma membrane? Our results showing the
expected molecular weight of the monomeric form of
NTD-KCC2 mutant suggest that the protein is at least
correctly translated and are consistent with a previous
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study (Horn et al., 2010). Also, the authors found that
NTD-KCC2 interacts with the neuronal cytoskeleton-
associated protein 4.1N similarly to the wild-type KCC2
and therefore suggested that NTD-KCC2 mutant is cor-
rectly folded. In that case, one can suggest that the
deletion of the N terminus perturbs the interaction of
KCC2 with surface-delivery machinery without affecting
structural integrity of the mutant. However, our finding of
the modified monomer/total protein ratio does not ex-
clude possible modifications in the tertiary/quaternary
structure of the NTD-KCC2 protein that could cause
the mutant to be stacked at one of the multiple check-
points of the secretory pathway. Future studies are
required to characterize in more detail the structural
changes associated with the deletion of the N terminus
of KCC2.
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Figure 7. Surface biotinylation of nontagged KCC2 mutants. A, Representative Western blots of total extracts (left) and biotinylated
fractions (right) of N2a cells transfected with wild-type KCC2 (WT), pcDNA3.1 (mock), and NTD-KCC2 (NTD). Detection with
anti-KCC2 rabbit (KCC2rab) antibody recognizing C terminus of KCC2. Anti–-transferrin receptor antibody (-tr) and anti–-tubulin
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Detection with anti-KCC2 chicken (KCC2chk) antibody recognizing N terminus of KCC2. C, Summary data of surface biotinylation
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are the same as detailed in Figure 1.
Table 4. Statistical differences among the samples illustrated in Figure 7
Location Data reference Data structure Type of test Power
a Fig. 7C Nonnormal distribution Wilcoxon matched pairs test
WT, KCC2rab vs. WT, Tub z 	 1.89, n 	 5; p 	 0.031
WT, KCC2rab vs. NTD, KCC2rab z 	 1.89, n 	 5; p 	 0.031
NTD, KCC2rab vs. NTD, Tub z 	 –0.27, n 	 5; p 	 0.69
b Fig. 7D Nonnormal distribution Wilcoxon matched pairs test
WT, KCC2chk vs. WT, Tub z 	 2.10, n 	 6; p 	 0.016
WT, KCC2chk vs. CTD, KCC2chk z 	 –1.26, n 	 6; p 	 0.92
CTD, KCC2chk vs. CTD, Tub z 	 –2.10, n 	 6; p 	 0.016
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We further highlighted the critical role of the N terminus
for KCC2 surface delivery using two constructs com-
posed only of N terminus and transmembrane regions
(CTD-KCC2-pHext and CTD-KCC2 mutants). Both mu-
tants were effectively inserted into the plasma membrane.
This observation provides a novel perception of the struc-
tural role of the C terminus in KCC2’s function and indi-
cates that the C terminal domain is not required for the
surface insertion of the transporter. However, after effec-
tive delivery to the plasma membrane, the CTD-KCC2-
pHext mutant was rapidly internalized, suggesting an
important role of the C terminus for KCC2 stabilization
into the plasma membrane. An alternative explanation
could be that because of a compromised structure and
folding, the protein undergoes rapid internalization to be
further degraded. This suggestion is in agreement with the
consistent observation of a smear-like pattern of migra-
tion for CTD-KCC2-pHext and CTD-KCC2 mutants. Yet
the mechanisms controlling the internalization and degra-
dation of KCC2 are out of the scope of the present work
and constitute a crucial subject for further studies.
Understanding the structure–function organization of
KCC2 transporter is a priority in the field, as KCC2 is a
putative target for development of therapeutic treatments
(Kahle et al., 2013; Löscher et al., 2013; Medina et al.,
2014). To date, most reported functionally important
KCC2 regulatory sites are located on the long intracellular
C terminus (Lee et al., 2007, 2010; Li et al., 2007; Rinehart
et al., 2009; Acton et al., 2012; Kahle et al., 2014; Puskar-
jov et al., 2014; Weber et al., 2014). The structure–function
importance of the intracellular N terminus of KCC2 is
much less studied. A recent work suggested the impor-
tance of KCC2 N terminus domain for the neuroprotection
(Winkelmann et al., 2015). The N terminus of KCC2 also
carries several putative regulatory sites, including phos-
phorylatable serine residues (Weber et al., 2014) and the
Ste20-related proline alanine-rich kinase/oxidative stress
response-1 (SPAK/OSR1) binding motif (Uvarov et al.,
2007); however, their functional importance remains ob-
scure. The present work provides an important clue for
further research directed to describe the mechanisms of
KCC2 surface insertion and the precise role of the N
terminus domain in this process. In addition to the surface
insertion mechanism, we have noticed the importance of
the N terminus for KCC2 expression into distal dendrites.
Indeed, the truncation of the N terminus of KCC2-pHext
resulted in decreased dendritic expression of the trans-
porter, whereas the construct composed of only the N
terminus and transmembrane domains showed twofold
higher dendritic expression. These results are in agree-
ment with similar findings reported by Winkelmann
et al. (2015). Although identification of the mechanisms
involved in the decreased expression of NTD-KCC2 in
the distal dendritic compartment was not in the scope
of the present study, our findings highlight one more
potential structure–function role for the N terminus re-
gion that should be taken into account in future exper-
iments.
The KCC2 mutant with deleted N terminus is widely
used as a molecular tool in studies to characterize mech-
anisms of regulatory actions of KCC2 (Li et al., 2007;
Bortone and Polleux, 2009; Horn et al., 2010; Gauvain
et al., 2011; Fiumelli et al., 2013; Winkelmann et al., 2015).
In particular, the experiments using NTD-KCC2 mutant
served as a key argument in the hypothesis of the struc-
tural (ion transport–independent) mechanism of KCC2’s
regulatory action (Li et al., 2007; Horn et al., 2010; Fiumelli
et al., 2013). Our finding does not place this hypothesis in
question, as NTD-KCC2 possesses the putative region
on the C terminus mediating the trophic action of KCC2
Figure 8. Scheme of the surface expression of different KCC2 mutants. Deletion of the N terminus abolishes plasmalemmal delivery
of the transporter, whereas deletion of the C terminus does not interrupt this process. Thus, the N terminus is indispensable for
KCC2’s surface delivery. The mutant with deleted C terminus is internalized more effectively than the wild-type KCC2 (left). We
postulate that wild-type KCC2 is stabilized in the plasma membrane using a putative anchoring protein that interacts with the C
terminus of the transporter (right).
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(Li et al., 2007), and overexpression of only intracellular C
terminus exerted a similar regulatory action (Fiumelli et al.,
2013); however, it should be considered for future work,
suggesting proper dendritic delivery and surface expres-
sion of the transporter.
In conclusion, our results support a novel view of the
role of the N terminus domain in the control of KCC2
surface expression. Because KCC2 is a putative target for
novel therapeutic treatments, our findings highlight the N
terminus as a crucial target for strategies designed to
enhance KCC2’s surface delivery.
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